5:49
Digital therapeutics in Canada versus the U.S.
Amos Adler, founder, and president at Memotext, discusses his company's flagship digital app for the schizophrenia and psychosis population and how its portal helps caregivers engage with patients and identify the risks for relapse and readmission.